Loading...

Blueprint Medicines Corporation

BPMC•NASDAQ
Healthcare
Biotechnology
$129.46
$0.18(0.14%)

Blueprint Medicines Corporation (BPMC) Stock Chart & Performance Analysis

Explore Blueprint Medicines Corporation’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
-2.17%
5-Day Change
-6.13%
1-Month Change
-7.41%
3-Month Change
-8.19%
6-Month Change
-7.70%
Year-to-Date (YTD) Change
-7.95%
1-Year Change
-11.29%
3-Year Change
20.94%
5-Year Change
25.60%
All-Time (Max) Change
325.38%

Analyzing Blueprint Medicines Corporation (BPMC) Trends Across Multiple Time Frames

Blueprint Medicines Corporation Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. Blueprint Medicines Corporation stock shows -2.17% 1-day change, indicating low volatility, while its 5-day change of -6.13% suggests a broader trend. Over a 1-month period, a -7.41% drop could signal a pullback, whereas a 3-month decline of -8.19% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of -7.70% and a YTD drop of -7.95% might concern investors, but a 1-year loss of -11.29% and a 3-year increase of 20.94% could indicate resilience. The 5-year surge of 25.60% highlights strong historical growth, while the all-time return of 325.38% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;